Lido Advisors’s Tenax Therapeutics TENX Stock Holding History

Lido Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125	Closed	-$2.99K	–	1433
2023 Q3	$2.99K	Buy	+125	New	+$3.17K	﹤0.01%	1206

Other funds holding TENX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lido Advisors's TENX Position: Q4 2023 in Review

Lido Advisors sold out of Tenax Therapeutics (TENX) in Q4 2023, closing a stake of 125 shares — an estimated $2.99K sold.

Lido Advisors first reported a position in TENX in Q3 2023 and held it in 1 quarter. The position peaked at $2.99K in Q3 2023. 16 funds tracked by Wall St. Rank hold TENX as of Q4 2023.

Lido Advisors reported no remaining Tenax Therapeutics position as of Q4 2023 after selling out during the quarter.
Lido Advisors sold 125 Tenax Therapeutics shares in Q4 2023, an estimated $2.99K.
Lido Advisors first reported a position in Tenax Therapeutics in Q3 2023 and held it in 1 quarter.
Lido Advisors's Tenax Therapeutics position peaked at $2.99K in Q3 2023.
16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2023.

Based on Lido Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.